The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis

Silva-Fernández, L, Lunt, M, Kearsley-Fleet, L et al. (5 more authors) (2016) The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis. Rheumatology, 55 (11). pp. 2033-2039. ISSN 1462-0324

Abstract

Metadata

Authors/Creators:
  • Silva-Fernández, L
  • Lunt, M
  • Kearsley-Fleet, L
  • Watson, KD
  • Dixon, WG
  • Symmons, DPM
  • Hyrich, KL
  • BSRBR Control Centre Consortium
Copyright, Publisher and Additional Information: (c) 2016, The Author. Published by Oxford University Press on behalf of the British Society for Rheumatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Keywords: rheumatoid arthritis, cancer, anti-TNF, rituximab, cohort study
Dates:
  • Accepted: 22 July 2016
  • Published (online): 22 August 2016
  • Published: November 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 01 Feb 2017 11:32
Last Modified: 05 Oct 2017 16:27
Published Version: https://doi.org/10.1093/rheumatology/kew314
Status: Published
Publisher: Oxford University Press
Identification Number: https://doi.org/10.1093/rheumatology/kew314

Share / Export

Statistics